RN 9893 hydrochloride
CAS: 1803003-68-0
Ref. 3D-DXC00368
| 5mg | 338.00 € | ||
| 10mg | 408.00 € | ||
| 25mg | 681.00 € | ||
| 50mg | 1,038.00 € | ||
| 100mg | 1,563.00 € |
Product Information
RN 9893 is a novel, non-peptide, orally available, small molecule that antagonizes the TGF-β1 receptor. This drug has been shown to inhibit cancer cell proliferation and tumor growth in vitro and in vivo. RN 9893 has also been shown to reduce microbial load in mice with disseminated candidiasis. Combination therapy with this compound was found to be more effective than monotherapy for the treatment of cancer cells. More research is needed before this drug can be used to treat human cancers.
Chemical properties
Technical inquiry about: 3D-DXC00368 RN 9893 hydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
